Leukocyte and endothelial adhesion molecule studies in knockout mice

Aman K Kakkar1, David J Lefer

  • 1Department of Medicine, Division of Cardiology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA.

Insights

Leukocyte adhesion molecules like CD18 and intercellular adhesion molecule-1 mediate heart injury after ischemia and reperfusion. Targeting these molecules reduces myocardial damage, offering therapeutic potential.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Inflammation Research

Background:

  • Myocardial ischemia and reperfusion (I/R) triggers an inflammatory response, with leukocytes contributing significantly to injury.
  • Leukocyte-endothelial cell adhesion molecules mediate neutrophil interactions in coronary vasculature post-I/R.

Purpose of the Study:

  • To investigate the role of specific adhesion molecules in mediating myocardial I/R injury.
  • To assess the therapeutic potential of targeting leukocyte-endothelial interactions.

Main Methods:

  • Studies involved genetic deficiency models (CD18, intercellular adhesion molecule-1, P-selectin, E-selectin deficient mice).
  • Evaluation of myocardial necrosis and neutrophil accumulation following I/R injury.

Main Results:

  • Genetic deficiency of CD18 significantly attenuated myocardial I/R injury.
  • Absence of intercellular adhesion molecule-1 minimized myocardial necrosis.
  • P-selectin and E-selectin deficiency studies showed reduced neutrophil accumulation and myocardial injury.

Conclusions:

  • Leukocyte adhesion molecules, including beta(2)-integrins (CD18) and intercellular adhesion molecule-1, are critical in mediating myocardial I/R injury.
  • Selectins also play a role in leukocyte-endothelial interactions during I/R.
  • Targeting these adhesion pathways presents a potential therapeutic strategy for reducing I/R-induced heart damage.